Wednesday 14 October 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
209.87
5.51
+2.70%
Follow MOH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (0.16%) | 4.48% | 11.02% | 19.71% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 6 | 4 | 4 | |
| (0.04%) | 1.15% | 3.03% | 5.61% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(0.13%) | 3.46% | 8.78% | 16.37% | |
Average Days of Receivables |
28.57 | 27.69 | 28.39 | 28.80 | |
Free Cash Flow per Share |
5.30 | 4.93 | (12.05) | (10.93) | |
Free Cash Flow |
271.00 | 251.00 | (636.00) | (574.00) | |
Capital Expenditures |
(94.00) | (106.00) | (101.00) | (113.00) | |
| Other line items | |||||
Cash ROIC |
1.59% | 1.45% | (3.91%) | (3.48%) | |
Accounts Receivable Turnover |
12.11 | 13.04 | 13.30 | 13.15 | |
Accounts Payable Turnover |
34.54 | 34.46 | 32.58 | 32.80 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
10.69 | 10.79 | 10.10 | 10.70 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.17 | (0.18) | (0.20) | (0.23) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.80% | 6.69% | 6.62% | 6.46% | |
Share Based Compensation of Revenue |
0.17% | 0.12% | 0.10% | 0.10% | |
Interest Coverage |
0.97 | 2.12 | 4.07 | 7.60 | |
Operating CF/Net income |
(52.14) | 1.90 | (1.13) | (0.52) | |
Depreciation/Fixed assets |
0.54 | 0.62 | 0.65 | 0.62 | |
Capex/Depreciation |
(0.56) | (0.57) | (0.52) | (0.57) | |
Revenue per Share |
871.27 | 885.56 | 860.34 | 848.57 | |
Operating CF per Share |
7.14 | 7.01 | (10.13) | (8.78) | |
Capex per Share |
(1.84) | (2.08) | (1.91) | (2.15) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates